Drug Shortage Report for TEVA-PRAVASTATIN

Last updated on 2022-12-22 History
Report ID 161003
Drug Identification Number 02247010
Brand name TEVA-PRAVASTATIN
Common or Proper name PRAVASTATIN 40MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) PRAVASTATIN SODIUM
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 P pack
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-05-18
Estimated end date 2022-12-30
Actual end date 2022-12-21
Shortage status Resolved
Updated date 2022-12-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2022-12-22 French Compare
v25 2022-12-22 English Compare
v24 2022-12-15 French Compare
v23 2022-12-15 English Compare
v22 2022-12-08 French Compare
v21 2022-12-08 English Compare
v20 2022-12-01 French Compare
v19 2022-12-01 English Compare
v18 2022-09-30 French Compare
v17 2022-09-30 English Compare
v16 2022-09-22 French Compare
v15 2022-09-22 English Compare
v14 2022-09-22 French Compare
v13 2022-09-22 English Compare
v12 2022-09-07 French Compare
v11 2022-09-07 English Compare
v10 2022-08-08 French Compare
v9 2022-08-08 English Compare
v8 2022-06-30 French Compare
v7 2022-06-30 English Compare

Showing 1 to 20 of 26